Publications (20) AMAIA ARRUABARRENA ARISTORENA publications

2022

  1. Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer

    Frontiers in Oncology, Vol. 12

  2. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer

    Oncogenesis, Vol. 11, Núm. 1

  3. The Oncogenic PI3K-Induced Transcriptomic Landscape Reveals Key Functions in Splicing and Gene Expression Regulation

    Cancer Research, Vol. 82, Núm. 12, pp. 2269-2280

2021

  1. FOXA1 mutations influence the therapeutic response of breast cancer by altering chromatin state

    Molecular and Cellular Oncology

  2. TRK XDFG mutations trigger a sensitivity switch from type i to ii kinase inhibitors

    Cancer Discovery, Vol. 11, Núm. 1, pp. 126-141

2020

  1. FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer

    Cancer Cell, Vol. 38, Núm. 4, pp. 534-550.e9

  2. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

    The Journal of experimental medicine, Vol. 217, Núm. 6

  3. Targeting PML in triple negative breast cancer elicits growth suppression and senescence

    Cell Death and Differentiation, Vol. 27, Núm. 4, pp. 1186-1199

2019

  1. PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression

    Cell Reports, Vol. 27, Núm. 1, pp. 294-306.e5

2018

  1. Low-dose statin treatment increases prostate cancer aggressiveness

    Oncotarget, Vol. 9, Núm. 2, pp. 1494-1504

  2. Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism

    Science Advances, Vol. 4, Núm. 1

  3. PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth

    Cancer Research, Vol. 78, Núm. 2, pp. 399-409

2017

  1. MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    Nature, Vol. 547, Núm. 7661, pp. 109-113

2016

  1. HEY1 functions are regulated by its phosphorylation at Ser-68

    Bioscience Reports, Vol. 36, Núm. 3

  2. Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells

    Leukemia, Vol. 30, Núm. 1, pp. 209-218

  3. Stratification and therapeutic potential of PML in metastatic breast cancer

    Nature Communications, Vol. 7

  4. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

  5. Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer

    Oncotarget, Vol. 7, Núm. 6, pp. 6835-6846

2015

  1. Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN

    Methods, Vol. 77, pp. 25-30

  2. PTEN mediates Notch-dependent stalk cell arrest in angiogenesis

    Nature Communications, Vol. 6